| Title: |
Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML |
| Authors: |
Ball, Brian J.Aff1, IDs1304502501724z_cor1; Xiao, WenbinAff2; Borthakur, GautamAff3; Nguyen, Le Xuan TruongAff1; Valerio, MelissaAff1; Venkatachalam, AvanthikaAff4; Marcucci, GuidoAff1; Stein, Anthony S.Aff1; Thai, Dung LuongAff5; Cook, David N.Aff5; Chan, KyleAff6; Persaud, SonaliAff2; Levine, Ross L.Aff2; Abdel-Wahab, OmarAff2; Ben-Neriah, YinonAff4; Stein, Eytan M.Aff2, IDs1304502501724z_cor2 |
| Source: |
Journal of Hematology & Oncology. 18(1) |
| Database: |
Springer Nature Journals |